Answers are grounded in this paper and cite their sources.
Sir, In a recent article, Tremellen and Savulescu (2014) ‘argue in support of screening the general population for diminished ovarian reserve (OR)’. They state that OR ‘is determined by the net result of the initial size of the primordial follicle endowment, the natural rate of atretic loss and the impact of any insult that may hasten follicle depletion’. However, OR is not defined, nor do they mention that OR is influenced by the rate at which primordial follicles are activated and leave the primordial follicle pool. They remark that anti-Müllerian hormone [AMH] and antral follicle count [AFC] are excellent quantitative markers of OR, but possibly do not reflect oocyte quality and therefore the chances of immediate natural conception. However, a poor AMH or AFC result does reflect a marked reduction in the chances of IVF-related conception. We support the call for methods to determine the OR as a means of informing women about their likely future fertility and reproductive lifespan, particularly those with a markedly reduced OR. It is not our purpose here to comment on the practical or ethical issues of screening for OR, but there is a need for critical analysis of what is meant by the term OR and the limitations of the use of AMH or AFC as a measure of it.
No takes yet. Share an insight, caveat, or question.
FINDLAY et al. (2015) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: